Indications and uses
To relieve the symptoms of colds.
To relieve the symptoms of colds.
Adults: 4 drops into a tsp. of water 3 times a day. Children: 1/2 dose. Repeat at greater intervals as condition subsides. Or as directed bya lic. practitioner.
DULCAMARA
To relieve the symptoms of colds.
Keep this and all medicines out of reach of children.
Indications:
DULCAMARA Colds
If symptoms persist/worsen or if pregnant/nursing, consult your practitioner.
Adults: 4 drops into a tsp. of water 3 times a day. Children: 1/2 dose. Repeat at greater intervals as condition subsides. Or as directed bya lic. practitioner.
Sucrose/Lactose
The OTC potency range of DULCAMARA is 2x–30x, 1c–30c, 200c, 1m, 10m, 50m, and CM.
Availability is subject to change.
All WHP single remedies are made to order; thus, the labels are printed on the same label stock, as the orders are filled.
‘Bottle Size,’ ‘Potency,’ and ‘Alcohol Percentage’ vary on the label depending on customer choice.
Standard bottle sizes for dilution-form remedies are 15ml, 30ml, 50ml, and 100ml.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0740640304228 | GTIN-13: 0740640304228 EAN-13: 0740640304228 GTIN-12: 740640304228 UPC-A: 740640304228 GTIN storage (14 digits): 00740640304228 | Dulcamara.jpg |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71919-261 | 71919-261-07, 71919-261-08, 71919-261-09, 71919-261-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| SOLANUM DULCAMARA TOP | KPS1B1162N | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dad03e8c-5d52-231d-e053-2995a90a7b05 | e6412405-74d5-4f7c-b851-ef9da9dda3f3 | 2022-03-22 | Warnings | e6412405-74d5-4f7c-b851-ef9da9dda3f3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.